Hanson Tang

Hanson Tang is an Executive Regulatory Sciences Director in the Immunology Franchise at AstraZeneca, where they lead a team of global regulatory leaders focused on advancing the company’s biopharmaceutical portfolio. They have extensive experience in regulatory affairs, having previously held leadership roles at GSK, Syngenta, and Nektar Therapeutics, among others. Hanson began their career as a QA Auditor at Bayer and has consistently contributed to the development and regulatory strategy for a variety of pharmaceutical products. They are pursuing a Bachelor of Arts in Biology at the University of Colorado Boulder.